NASDAQ: IRMD
Iradimed Corp Earnings Dates, Reports, Calls

Iradimed earnings were $18.6M for the trailing 12 months ending Sep 30, 2024, with 14.7% growth year over year. The latest IRMD earnings report on Sep 30, 2024 announced Q3 2024 earnings of $5.0M, up 3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IRMD reported annual earnings of $17.2M, with 34% growth.

IRMD past earnings growth

How has IRMD's earnings growth performed historically?

Company
14.73%
Industry
32.37%
Market
53.89%
IRMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IRMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IRMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IRMD earnings history

Current Revenue
$71.3M
Current Earnings
$18.6M
Current Profit Margin
26.1%
IRMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IRMD Return on Equity

Current Company
24%
Current Industry
11.4%
Current Market
35%
IRMD's Return on Equity (24%)... subscribe to Premium to read more.
High Return on Equity Performance

IRMD Return on Assets

Current Company
20.4%
Current Industry
6.6%
IRMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IRMD announces earnings.

IRMD Return on Capital Employed

Current Company
27.4%
Current Industry
8.8%
IRMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IRMD$24.44M$18.63M+14.87%$1.48
OFIX-$38.97M-$119.03MN/A-$3.13
SIBN-$29.13M-$37.40MN/A-$0.92
CTKB-$649.00k-$10.16M+3,609.96%$940.91
SENS-$71.00M-$80.33MN/A-$0.13

Iradimed Earnings Reports & History FAQ

What were Iradimed's earnings last quarter?

On IRMD's earnings call on Invalid Date, Iradimed (NASDAQ: IRMD) reported Q3 2024 earnings per share (EPS) of $0.40, up 0% year over year. Total IRMD earnings for the quarter were $5.05 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.40.

If you're new to stock investing, here's how to buy Iradimed stock.

Is Iradimed profitable or losing money?

As of the last Iradimed earnings report, Iradimed is currently profitable. Iradimed's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $18.63 million, a 14.09% increase year over year.

What was IRMD's earnings growth in the past year?

As of Iradimed's earnings date in Invalid Date, Iradimed's earnings has grown 14.73% year over year. This is 17.64 percentage points lower than the US Medical Devices industry earnings growth rate of 32.37%. IRMD earnings in the past year totalled $18.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.